$7.4 M

BIOC Mkt cap, 09-Nov-2018

$822.2 K

Biocept Revenue Q2, 2018
Biocept Gross profit (Q2, 2018)-1.9 M
Biocept Gross profit margin (Q2, 2018), %(228.3%)
Biocept EBIT (Q2, 2018)-6 M
Biocept Cash, 30-Jun-20182.6 M

Biocept Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

5.1m

Cost of goods sold

4.6m6.9m9.3m

Gross profit

(4.3m)

Gross profit Margin, %

(84%)

Sales and marketing expense

3.9m5.1m6.3m

R&D expense

2.9m2.7m3.4m

General and administrative expense

5.7m6.6m7.2m

Operating expense total

17.0m21.2m26.2m

EBIT

(16.4m)(18.0m)(21.2m)

EBIT margin, %

(418%)

Interest expense

640.5k525.9k482.6k

Pre tax profit

(16.9m)(18.4m)(21.6m)

Income tax expense

(1.6k)(2.1k)(7.6k)

Net Income

(15.9m)(16.9m)(18.4m)

Biocept Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

5.4m8.8m4.6m2.1m

Accounts Receivable

10.6k34.2k129.0k1.2m

Inventories

338.7k435.9k484.6k498.7k

Current Assets

5.9m9.6m5.8m4.3m

PP&E

3.1m

Total Assets

6.6m10.6m7.6m7.4m

Accounts Payable

641.4k632.5k960.5k1.3m

Current Liabilities

1.4m3.3m4.4m4.7m

Long-term debt

5.2m

Total Liabilities

6.9m6.1m

Additional Paid-in Capital

138.1m158.9m174.3m196.5m

Retained Earnings

(138.3m)(155.2m)(173.6m)(195.2m)

Total Equity

658.7k1.3m

Financial Leverage

11.5 x5.7 x

Biocept Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(15.9m)(16.9m)(18.4m)(21.6m)

Depreciation and Amortization

251.2k261.4k322.0k575.7k

Accounts Receivable

(1.4k)(23.6k)(94.8k)(1.1m)

Inventories

(401.4k)(80.4k)494.7k100.9k

Accounts Payable

(981.9k)(51.8k)332.7k349.9k

Cash From Operating Activities

(14.6m)(15.2m)(15.7m)(19.7m)

Cash From Investing Activities

(394.9k)(165.2k)(451.4k)(1.4m)

Cash From Financing Activities

20.3m18.8m11.9m18.6m

Interest Paid

402.1k405.7k358.6k358.5k

Income Taxes Paid

800.02.2k2.1k5.3k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(5.1m)(8.1m)(12.0m)

Depreciation and Amortization

57.7k112.2k177.5k

Accounts Receivable

(16.8k)(19.2k)(3.2k)15.6k32.1k40.4k43.4k86.7k85.7k834.9k994.7k

Inventories

(3.5k)(41.8k)(46.2k)412.9k

Accounts Payable

(830.7k)(865.6k)(992.4k)970.5k612.5k766.4k853.3k946.3k1.7m1.4m1.8m1.6m

Cash From Operating Activities

(5.1m)(8.0m)(11.4m)

Cash From Investing Activities

(6.3k)(201.8k)

Cash From Financing Activities

15.4m20.4m20.3m

Interest Paid

152.5k196.2k298.4k

Income Taxes Paid

800.0800.0

Biocept Ratios

USDY, 2018

Financial Leverage

3.3 x
Report incorrect company information

Biocept Employee Rating

3.14 votes
Culture & Values
4.3
Work/Life Balance
2.9
Senior Management
3.0
Salary & Benefits
3.1
Career Opportunities
2.5
Source